![]() ITH Pharma ITH Pharma is a new pharmaceutical company committed to the research and development of aseptic preparations and to providing an unrivalled customer service. | ![]() Divis Laboratories Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. | |||
Founding Date | Founding Date 2008 | Founding Date 1971 | Founding Date 1990 | Founding Date 1954 |
Type | Type Private | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Greater London, GB HQ | Locations Ahmedabad, IN HQ São Paulo, BR Nürnberg, DE 32 No Market, IN Bengaluru, IN Chennai, IN Dahej, IN see more | Locations Hyderabad, IN HQ Choutuppal, IN Thondangi, IN Visakhapatnam, IN Basel, CH Basel, CH Florham Park, US | Locations SI HQ |
Employees | Employees 1843% increase | Employees 15,718 | Employees 7,9267% increase | Employees 132,447 |
Financial | ||||
Revenue (est.) | Revenue (est.) £48.3m (FY, 2018) | Revenue (est.) ₹137.5b (FY, 2026) | Revenue (est.) ₹105.6b (FY, 2026) | Revenue (est.) €2b (FY, 2025) |
Cost of goods | Cost of goods £33.5m (FY, 2018) | Cost of goods ₹33.9b (FY, 2026) | Cost of goods ₹40.9b (FY, 2026) | Cost of goods €764m (FY, 2025) |
Gross profit | Gross profit £14.8m (FY, 2018) | Gross profit ₹105b (FY, 2026) | Gross profit ₹69.7b (FY, 2026) | Gross profit €1.3b (FY, 2025) |
Net income | Net income £3.1m (FY, 2018) | Net income ₹21.4b (FY, 2026) | Net income ₹25.7b (FY, 2026) | Net income €403.7m (FY, 2025) |

Manufactures wide range of pharmaceutical products.
View company
Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates.
View company